Vivos Therapeutics Inc. (NASDAQ: VVOS)
$4.3700
N/A ( +0.23% ) 317.6K
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Market Data
Open
$4.3700
Previous close
$4.3700
Volume
317.6K
Market cap
$25.74M
Day range
$4.0620 - $4.5950
52 week range
$1.9100 - $9.1391
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 28, 2024 |
8-k | 8K-related | 13 | Jun 25, 2024 |
8-k | 8K-related | 14 | Jun 14, 2024 |
8-k | 8K-related | 13 | May 17, 2024 |
8-k | 8K-related | 14 | May 15, 2024 |
10-q | Quarterly Reports | 79 | May 14, 2024 |
8-k | 8K-related | 14 | May 06, 2024 |
8-k | 8K-related | 14 | Mar 29, 2024 |
10-k | Annual reports | 92 | Mar 28, 2024 |